Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Citations per year, relative to Robert C. Young Robert C. Young (= 1×)
peers
Raymond W. Klecker
Countries citing papers authored by Robert C. Young
Since
Specialization
Citations
This map shows the geographic impact of Robert C. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Young more than expected).
This network shows the impact of papers produced by Robert C. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Young. The network helps show where Robert C. Young may publish in the future.
Co-authorship network of co-authors of Robert C. Young
This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Young.
A scholar is included among the top collaborators of Robert C. Young based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Robert C. Young. Robert C. Young is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Fojo, Antonio Tito, Thomas C. Hamilton, Robert C. Young, & R F Ozols. (1987). Multidrug resistance in ovarian cancer. Cancer. 60(S8). 2075–2080.78 indexed citations
Matis, Louis A., Robert C. Young, Dan L. Longo, & Carol S. Portlock. (1986). Nodular lymphomas: Current concepts. Critical Reviews in Oncology/Hematology. 5(2). 171–197.11 indexed citations
5.
Hamilton, Thomas C., Robert C. Young, Karen G. Louie, et al.. (1984). Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice.. PubMed. 44(11). 5286–90.138 indexed citations
6.
Hamilton, Thomas C., Robert C. Young, & Robert F. Ozols. (1984). Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches.. PubMed. 11(3). 285–98.144 indexed citations
Garvin, A. Julian, Richard Simon, Robert C. Young, Vincent T. DeVita, & CW Berard. (1980). The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.. PubMed. 7(3). 234–43.38 indexed citations
9.
Ozols, Robert F., James K. V. Willson, Karen R. Grotzinger, & Robert C. Young. (1980). Cloning of human ovarian cancer cells in soft agar from malignant and peritoneal washings.. PubMed. 40(8 Pt 1). 2743–7.58 indexed citations
10.
Ozols, R F, James K. V. Willson, & Robert C. Young. (1980). Human ovarian cancer colony formation: growth from malignant washings and pharmacologic applications.. PubMed. 48. 247–57.2 indexed citations
Bobrow, Samuel N., Elaine S. Jaffe, & Robert C. Young. (1972). Anuria and acute tubular necrosis associated with gentamicin and cephalothin.. PubMed. 222(12). 1546–7.71 indexed citations
Young, Robert C., Vincent T. DeVita, & Seymour Perry. (1969). The thymidine-14C and -3H double-labeling technic in the study of the cell cycle of L1210 leukemia ascites tumor in vivo.. PubMed. 29(8). 1581–4.26 indexed citations
18.
Young, Robert C., et al.. (1969). Lymphoid interstitial pneumonia with polyclonal gammopathy. A case report.. PubMed. 61(4). 310–4.15 indexed citations
Young, Robert C., et al.. (1969). Lobar pneumonia due to aspergillus fumigatus.. PubMed. 14(2). 169–74.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.